At a glance
ClinicalIndex Comparison RecordN/ACompleted· 21 enrolled
Drug / intervention
Default 4 days antibiotic therapydrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Clinical Trial of 4 vs. 8 Days of Definitive Antibiotic Therapy for Early Ventilator-Associated Pneumonia in the Surgical Intensive Care Unit
In Brief
A clinical study evaluating Default 4 days antibiotic therapy for Early Ventilator Associated Pneumonia. Completed, enrolled 21 participants across 1 site.
Detailed Summary
Hypothesis: 4 days of antibiotic therapy, as compared to 8 days, is equally effective and results in decreased antibiotic exposure among surgical ICU patients with early VAP.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEarly Ventilator Associated Pneumonia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedNov 2013
Enrollment StartDec 2013
Primary CompletionNov 2021
TodayJul 2026
First PostedNov 26, 2013
Enrollment StartDec 1, 2013
Primary CompletionNov 5, 2021
TodayJul 2, 2026
Enrollment to primary: 7.9 yearsPosted 12.6 years ago
Interventions
Default 4 days antibiotic therapydrug
The intervention for this trial involves a shorter duration of antibiotic therapy. Specifically, a default of 4 vs. 8 days.